Abstract:AbstractBackgroundLipopolysaccharide (LPS) derived from the human gastrointestinal (GI)‐tract microbiome: (i) has been recently shown to target, accumulate within, and eventually encapsulate neuronal nuclei of the human central nervous system (CNS) in Alzheimer’s disease (AD) brain; and (ii) recent evidence indicates that this action appears to restrict the outward flow of genetic information from neuronal nuclei. It has previously been shown that in LPS‐encased neuronal nuclei in AD brain there is a specific disruption in the output and expression of two AD‐relevant, neuron‐specific markers encoding the cytoskeletal neurofilament light (NF‐L) chain protein and the synaptic phosphoprotein synapsin‐1 (SYN1) involved in the regulation of neurotransmitter release. The biophysical mechanisms involved in the facilitation of the targeting of LPS to neuronal cells and nuclei, and eventual nuclear envelopment and functional disruption are not entirely clear.MethodIsolation of lipopolysaccharide (LPS), bacterial amyloid(s), enterotoxin(s) and small non‐coding RNAs (sncRNAs) from Gram‐negative anaerobic bacilli of the human gastrointestinal (GI) tract; isolation of human temporal lobe neocortical, hippocampal and retinal tissues; aging 5xFAD (amyloid over‐expressing; C57BL6 background); RNA sequencing; LED Northern dot blots; Western analysis, immunocytochemistry; biostatistics, bioinformaticsResultIn this presentation we will (i) provide novel evidence in human neuronal‐glial (HNG) cells in primary co‐culture that the incubation of LPS with amyloid‐beta 42 (Aβ42) peptides facilitates the association of lipoglycans such as LPS with neuronal cells; and (ii) that a similar phenomenon is observed in the brains of 5xFAD transgenic mice, an amyloid over‐expressing transgenic model of AD as well as in AD‐affected neocortex and hippocampal CA1.ConclusionThese novel findings: (i) support a novel pathogenic role for Aβ42 peptides in neurons via the formation of pores across the nuclear membrane and/or a significant biophysical disruption of the neuronal nuclear envelope; and (ii) advance the concept that the Aβ42 peptide‐facilitated entry of LPS into brain neurons, accession of neuronal nuclei, and down‐regulation of neuron‐specific components such as NF‐L and SYN1 may contribute significantly to neuropathological deficits as are characteristically observed in AD‐affected brain.

New Evidence for P-gp-Mediated Export of Amyloid-β Peptides in Molecular, Blood-Brain Barrier and Neuronal Models

P2‐347: Absence of MDR‐1 P‐glycoprotein at the Blood‐brain Barrier Increased the Passage of Blood‐borne Exogenous Aβ Peptides Across the BBB into the Brain

Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease

Absence of MDR-1 P-glycoprotein at the blood-brain barrier increased the passage of blood-borne exogenous Aβ peptides across the BBB into the brain

P2X receptor overexpression induced by soluble oligomers of amyloid beta peptide potentiates synaptic failure and neuronal dyshomeostasis in cellular models of Alzheimer's disease

Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease.

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Correction: Blood-brain Barrier-Associated Pericytes Internalize and Clear Aggregated Amyloid-Β42 by LRP1-dependent Apolipoprotein E Isoform-Specific Mechanism.

The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer’s disease

Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems

Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms

The Relationship among Amyloid-Β Deposition, Sphingomyelin Level, and the Expression and Function of P-glycoprotein in Alzheimer’s Disease Pathological Process

Glutamate and Γ-Aminobutyric Acid Differentially Modulate Glymphatic Clearance of Amyloid Β Through Pulsation- and Aquaporin-4 Dependent Mechanisms

Amyloid BETA‐42 Peptides Facilitate the Entry of Gastrointestinal Tract Microbiome‐derived Lipopolysaccharide into Human Neurons

P-glycoproteins in the Pathology and Treatment of Alzheimer's Disease

Brain Microvascular Endothelial Cell Derived Exosomes Potently Ameliorate Cognitive Dysfunction by Enhancing the Clearance of Aβ Through Up-Regulation of P-gp in Mouse Model of AD

RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an in Vitro BBB Model

Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance

S4-03-01: Evidence That Aberrant Post-Tgn Trafficking of Alzheimer’s APP is Sufficient to Elevate Brain A-beta 42 and May Underlie Mutant Presenilin Action